| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
208,785,000 |
| Market
Cap: |
47.11(B) |
| Last
Volume: |
1,348,221 |
Avg
Vol: |
0 |
| 52
Week Range: |
$137 - $231.92 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 767 |
| Guru Rank Value : 3 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile IQVIA Holdings is a provider of analytics, technology solutions, and clinical research services to the life sciences industry. Co. is managed through three reportable segments: Technology and Analytics Solutions, which provides information, technology solutions and real-world insights and services to its life science clients; Research and Development Solutions, which primarily serves biopharmaceutical customers and provides outsourced clinical research and clinical trial related services; and Contract Sales and Medical Solutions, which provides health care provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the healthcare market.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
1,275 |
1,275 |
| Total Buy Value |
$0 |
$0 |
$255,740 |
$255,740 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
60,557 |
66,906 |
66,906 |
137,059 |
| Total Sell Value |
$13,339,919 |
$14,547,359 |
$14,547,359 |
$31,939,656 |
| Total People Sold |
2 |
3 |
3 |
5 |
| Total Sell Transactions |
2 |
4 |
4 |
10 |
| End Date |
2025-09-04 |
2025-06-03 |
2024-12-03 |
2023-12-04 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bousbib Ari |
See Remarks |
• • – |
2025-10-29 |
4 |
D |
$220.96 |
$4,647,894 |
D/D |
(21,035) |
807,163 |
|
- |
|
| Bousbib Ari |
See Remarks |
• • – |
2025-10-29 |
4 |
S |
$217.58 |
$12,461,119 |
D/D |
(56,557) |
828,198 |
|
-6% |
|
| Bousbib Ari |
See Remarks |
• • – |
2025-10-29 |
4 |
OE |
$59.90 |
$4,647,761 |
D/D |
77,592 |
884,755 |
|
- |
|
| Sherbet Eric |
See Remarks |
• – – |
2025-10-29 |
4 |
D |
$219.72 |
$1,318,320 |
D/D |
(6,000) |
21,108 |
|
- |
|
| Sherbet Eric |
See Remarks |
• – – |
2025-10-29 |
4 |
S |
$219.70 |
$878,800 |
D/D |
(4,000) |
27,108 |
|
-6% |
|
| Sherbet Eric |
See Remarks |
• – – |
2025-10-29 |
4 |
OE |
$131.82 |
$1,318,200 |
D/D |
10,000 |
31,108 |
|
- |
|
| Patel Bhavik |
See Remarks |
• – – |
2025-07-28 |
4 |
D |
$197.76 |
$16,612 |
D/D |
(84) |
1,040 |
|
- |
|
| Cherofsky Keriann |
See Remarks |
• – – |
2025-07-28 |
4 |
D |
$197.76 |
$6,922 |
D/D |
(35) |
2,875 |
|
- |
|
| Cherofsky Keriann |
See Remarks |
• – – |
2025-07-23 |
4 |
S |
$191.53 |
$105,150 |
D/D |
(549) |
2,910 |
|
-18% |
|
| Sherbet Eric |
See Remarks |
• – – |
2025-07-23 |
4 |
D |
$190.10 |
$1,153,907 |
D/D |
(6,070) |
21,108 |
|
- |
|
| Sherbet Eric |
See Remarks |
• – – |
2025-07-23 |
4 |
S |
$190.05 |
$1,102,290 |
D/D |
(5,800) |
27,178 |
|
-18% |
|
| Sherbet Eric |
See Remarks |
• – – |
2025-07-23 |
4 |
OE |
$97.20 |
$1,153,764 |
D/D |
11,870 |
32,978 |
|
- |
|
| Goggins Colleen A |
Director |
– • – |
2025-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,592 |
12,882 |
|
- |
|
| Leonard John M. |
Director |
– • – |
2025-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,592 |
15,375 |
|
- |
|
| Danhakl John G |
Director |
– • – |
2025-04-24 |
4 |
A |
$0.00 |
$0 |
I/I |
1,592 |
29,041 |
|
- |
|
| Sherbet Eric |
See Remarks |
• – – |
2025-02-10 |
4 |
D |
$206.97 |
$37,048 |
D/D |
(179) |
21,108 |
|
- |
|
| Patel Bhavik |
See Remarks |
• – – |
2025-02-10 |
4 |
D |
$206.97 |
$22,353 |
D/D |
(108) |
1,124 |
|
- |
|
| Bousbib Ari |
See Remarks |
• • – |
2025-02-10 |
4 |
D |
$206.97 |
$690,245 |
D/D |
(3,335) |
807,163 |
|
- |
|
| Bousbib Ari |
See Remarks |
• • – |
2025-02-10 |
4 |
D |
$206.97 |
$5,502,297 |
D/D |
(26,585) |
810,498 |
|
- |
|
| Bousbib Ari |
See Remarks |
• • – |
2025-02-10 |
4 |
OE |
$65.16 |
$2,606,400 |
D/D |
40,000 |
837,083 |
|
- |
|
| Bruehlman Ronald E |
See Remarks |
• – – |
2025-02-10 |
4 |
D |
$206.97 |
$187,722 |
D/D |
(907) |
34,569 |
|
- |
|
| Cherofsky Keriann |
See Remarks |
• – – |
2025-02-10 |
4 |
D |
$206.97 |
$3,312 |
D/D |
(16) |
3,459 |
|
- |
|
| Staub W Richard |
See Remarks |
• – – |
2025-02-10 |
4 |
D |
$206.97 |
$29,183 |
D/D |
(141) |
16,896 |
|
- |
|
| Staub W Richard |
See Remarks |
• – – |
2025-01-28 |
4 |
D |
$203.43 |
$97,443 |
D/D |
(479) |
17,037 |
|
- |
|
| Staub W Richard |
See Remarks |
• – – |
2025-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,571 |
17,516 |
|
- |
|
452 Records found
|
|
Page 1 of 19 |
|
|
2.84 (1.24%) 
